Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for reducing or eliminating the need for lipoprotein apheresis in patients with hyperlipidemia by administering alirocumab

Methods for reducing or eliminating the need for lipoprotein apheresis in patients with hyperlipidemia by administering alirocumab

US Patent 11904017 · Granted Feb 20, 2024

Estimated economic value: $277,741,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of sepsis with PCSK9 and LDLR modulators2025
Methods for increasing lean body mass with an exercise regimen and a GDF8 inhibi2024
Methods for treating patients with heterozygous familial hypercholesterolemia (h2022
Methods for altering body composition by administering a GDF8 inhibitor and an A2022
Methods for increasing lean body mass with resistance training and a GDF8 inhibi2021
Methods for reducing or eliminating the need for lipoprotein apheresis in patien2020
Methods for reducing or eliminating the need for lipoprotein apheresis in patien2020
Methods for treating patients with heterozygous familial hypercholesterolemia (h2020
Dosing regimens for use with PCSK9 inhibitors2019
Methods for reducing remnant cholesterol and other lipoprotein fractions by admi2018
Methods for treating hypercholesterolemia and reducing LDL-C using antibodies to2017